DEREPRESSION OF HUMAN ENDOGENOUS RETROVIRUS AND IMPLICATIONS FOR IMMUNOTHERAPY FOR CLEAR CELL RENAL CELL CARCINOMA

$347,100FY2022Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators